Addressing the Theoretical and Clinical Advantages of Combination Therapy With Inhibitors of the Renin–angiotensin–aldosterone System: Antihypertensive Effects and Benefits Beyond BP Control
Life Sciences - United States
doi 10.1016/j.lfs.2009.11.020
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2010
Authors
Publisher
Elsevier BV